Case report: Multiple Sclerosis after COVID-19 infection
DOI:
https://doi.org/10.33448/rsd-v11i15.36799Keywords:
COVID-19; Multiple sclerosis; Optic neuritis.Abstract
In December 2019, a new Coronavirus disease called COVID-19, broke out in China, expanding across the world evolving into a worrying pandemic. According to the Ministry of Health, until May 31, 2022, there were 30.977.661 cases of COVID-19 in Brazil and approximately 666.516 deaths were recorded. The pandemic has caused important consequences in all sectors such as high unemployment rates, economy, education, and health, bringing a chronic underfunding of the Unified Health System (SUS), generating an unprecedented health crisis. COVID-19 is a disease caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). Symptoms of SARS-CoV-2 infection can include fever, cough, loss of smell and taste, sore throat, headache, diarrhea and fatigue, which can vary from person to person, however, most infected people can remain asymptomatic or develop mild to moderate symptoms, without the need for hospital intervention. However, some individuals can progress from severe pneumonia to respiratory failure, septic shock, and possibly death. In this study, we report a case of a 42-year-old Brazilian woman diagnosed with Multiple Sclerosis (MS) after COVID-19 infection, alerting to the association of post-COVID-19 MS. Although the mechanism of the relationship between MS and COVID-19 is not studied here, the study highlights this possibility and the importance of investigating symptoms such as paresthesias, muscle weakness and visual symptoms after SARS-CoV-2 infection.
References
Abboud, Hilal et al. (2020). COVID-19 and SARS-Cov-2 Infection: Pathophysiology and Clinical Effects on the Nervous System. World Neurosurgery, 140: 49–53. 10.1016/j.wneu.2020.05.193.
Andersen, O., Lygner, P.E., Bergström, T., Andersson, M. & Vablne, A. (1993). Infecções virais desencadeiam recaídas de esclerose múltipla: um estudo soroepidemiológico prospectivo. J. Neurol, 240, 417-422.
Arbor, N., Dia, R., Newcombe, J., & Talbot, P.J. (2000). Neuroinvasão por coronavírus respiratório humano. J Virol, 74:8913-8921.
Bohmwald, K., Gálvez, N. M. S., Ríos, M., & Kalergis, A. M. (2018). Neurologic Alterations Dueto Respiratory Virus Infections. Frontiers in CellularNeuroscience, 12 (October), 1–15.
Buscarinu, M.C., Fornasiero, A., Romano, S. et al (2019). A contribuição das alterações da barreira intestinal para a fisiopatologia da esclerose múltipla. Front Immuno, 10:1916.
Cucinotta, D., & Vanelli, M., (2020). A OMS declara o COVID-19 uma pandemia. Acta Biomed, 91, 157-160.
Donati, D. (2020). Infecções virais e esclerose múltipla. Descoberta de Drogas Hoje Des. Modelos, 32, 27-33.
Fotuhi, Majid et al. (2020). Neurobiology of COVID-19. Journal of Alzheimer’s Diseas, 76 (1), 3-19.
Guidon, A. C., & Amato, A. A. (2020). COVID-19 and neuromuscular disorders. Neurology, 94 (22), 959–969.
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei,Y., Wu, W., Xie, X., Yin, W., Li, H., Liu, M., Xiao, Y., Gao, H., Guo, L., Xie, J., Wang, G., Jiang, R., Gao, Z., Jin, Q., Wang, J. & Cao, B. (2020). Características clínicas de pacientes infectados com o novo coronavírus de 2019 em Wuhan, China. Lancet, 395(10223): 497–506.
Khatoon, F., Prasad, K. & Kumar, V. (2020). Neurological manifestations of COVID-19: availableevidencesand a new paradigm. Journal Of Neuroviroly. 26(5): 619–630.
Koralink, I. J. & Tyler, K. L. (2022). COVID ‐19: a global threattothenervous system. Annals Of Neurolog, 88 (1), 1-11.
Lin, Q., Zhao, S., Gao, D., Lou, Y., Yang, S., Musa, S.S., Wang, M.H., Cai, Y., Wang, W., Yang, L. & He, D. (2020) Um modelo conceitual para o surto da doença corona vírus 2019 (COVID-19) em Wuhan, China com reação individual e ação governamental. Int J Infect D, 93: 211–216.
Liu, Y., Gayle, A.A., Wilder-Smith, A. & Rocklov, J. (2020). O número reprodutivo do COVID-19 é maior em comparação com o coronavírus SARS. J Travel Med, 27(2): 021.
Marrodan, M., Alessandro, L., Farez, M.F. & Correale, J. (2019). O papel das infecções na esclerose múltipla. Mult. Escler. J, 25, 891-901.
Matías-Guiu, J., Gomez-Pinedo, U., Montero-Escribano, P., Gomez-Iglesias, P., Porta Etessam, J. & Matias-Guiu, J.Á. (2020). Devemos esperar sintomas neurológicos na epidemia de SARS-CoV-2? Neurologia, 35, 170-175.
McKay, K.A., Jahanfar, S., Duggan, T., Tkachuk, S., & Tremlett, H. (2017). Fatores associados ao início, recaídas ou progressão na esclerose múltipla: uma revisão sistemática. Neurotoxicologia, 61, 189-212.
Nassif-Pires, L., Carvalho, L. & Rawet, E. (2020). Multidimensional inequality and COVID-19 in Brazil. Blithewood: Levy Economics Institute of Bard College. Public Policy Brief, 153.
Natoli, S., Oliveira, V. Calabresi, P et al. (2020). O SARS-Cov-2 invade o cérebro? Lições translacionais de modelos animais. European Journal of Neurology, 27: 1764–177.
Oliveira, R.G., Cunha, A.P., Gadelha AGS, Carpio, C.G., Oliveira, R.B., & Corrêa, R.M. (2020). Desigualdades raciais e a morte como horizonte: considerações sobre a COVID-19 e o racismo estrutural. Cad Saúde Pública, 36:e00150120.
Painel Coronavirus, (2022). In: Coronavirus Brasil. Brasília: DataSUS. https://covid.saude.gov.br/.
Reich, D.S., Lucchinetti, C.F., & Calabresi. (2018). PA Esclerose múltipla. N. Engl. J. Med, 378, 169-180.
Rohit, A., Rajasekaran, S., Karunasagar, I., & Karunasagar, I. (2020). Destino de gotículas respiratórias em ambientes tropicais vs temperados e implicações para a transmissão de SARS-CoV-2. Hipóteses Médica, 144: 109958
Savarin, C., & Bergmann, C.C. (2017). Supressão induzida por vírus de células T autorreativas: lições da desmielinização neurotrópica induzida por coronavírus. J. Neuroimunol, 308, 12-16.
Shindler, K.S., Kenyon, L.C., Dutt, M., Hingley, S.T., Das, S.J. (2008). Neurite óptica experimental induzida por uma cepa desmielinizante do vírus da hepatite do rato. J. Virol. 82, 8882-8886.
Thompson, A.J., Baranzini, S.E., Geurts, J., Hemmer, B., & Ciccarelli, O. (2018). Esclerose múltipla. The Lancet, 391, 1622-1636.
Vieira, S., & Hossne, W. S. (2003). Metodologia científica para a área de saúde. In Metodologia científica para a área de saúde (pp. 192-192).
Werneck, G.L, & Carvalho, M.S. (2020). A pandemia de COVID-19 no Brasil: crônica de uma crise sanitária anunciada. Cad Saúde Pública, 36: e00068820.
Zhai, P., Ding, Y., Wu, X., Long, J., Zhong Y. & Li, Y. (2020). A epidemiologia, diagnóstico e tratamento do COVID-19. Agentes Antimicrobianos. Int J, 55(5): 105955.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Daiane Maria Pastorio; Eduardo Alexandre Loth
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
